DWRKF logo

Drägerwerk AG & Co. KGaA (DWRKF)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Drägerwerk AG & Co. KGaA (DWRKF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 49/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 15. März 2026
49/100 KI-Bewertung

Drägerwerk AG & Co. KGaA (DWRKF) Gesundheitswesen & Pipeline-Uebersicht

CEOStefan A. Drager
Mitarbeiter15170
HauptsitzLübeck, DE
IPO-Jahr2017

Drägerwerk AG & Co. KGaA, founded in 1889, is a global leader in medical and safety technology, offering a diverse portfolio of products and services ranging from acute care solutions to personal protection equipment, serving both healthcare and industrial sectors with a strong presence in Europe, the Americas, Asia, and Australia.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 15. März 2026

Investmentthese

Drägerwerk AG & Co. KGaA presents a compelling investment case based on its established market position and diversified product portfolio. The company's focus on both medical and safety technology provides resilience across economic cycles. Growth catalysts include increasing demand for advanced medical equipment and stringent safety regulations in industrial sectors. The company's P/E ratio of 13.39, as of 2026-03-15, suggests a potentially undervalued opportunity compared to its peers. The company's beta of -0.19 indicates lower volatility than the market, making it a noteworthy option for risk-averse investors. However, investors should monitor the impact of currency fluctuations and raw material costs on profitability.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Drägerwerk AG & Co. KGaA operates in the medical and safety technology sectors, providing a diversified revenue stream.
  • The company's global presence across Europe, the Americas, Africa, Asia, and Australia reduces regional risk.
  • Drägerwerk's product portfolio includes both medical devices and safety equipment, offering resilience to sector-specific downturns.
  • The company's P/E ratio of 13.39 suggests a potentially attractive valuation compared to industry peers.
  • A beta of -0.19 indicates lower volatility compared to the broader market.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diversified product portfolio across medical and safety technology.
  • Global presence and distribution network.
  • Strong brand reputation and established market position.
  • Focus on innovation and technological leadership.

Schwaechen

  • Exposure to currency fluctuations.
  • Dependence on regulatory approvals.
  • Competition from larger players in certain market segments.
  • Potential for product liability claims.

Katalysatoren

  • Upcoming: Potential new product launches in medical devices sector.
  • Ongoing: Increasing demand for safety equipment due to stricter regulations.
  • Ongoing: Expansion into emerging markets with growing healthcare infrastructure.
  • Upcoming: Potential partnerships to expand product offerings.
  • Ongoing: Continued innovation in gas detection technologies.

Risiken

  • Potential: Economic downturns affecting healthcare spending.
  • Potential: Changes in government regulations impacting medical device approvals.
  • Ongoing: Exposure to currency fluctuations.
  • Potential: Increased competition from low-cost manufacturers.
  • Ongoing: Product liability claims.

Wachstumschancen

  • Growth opportunity 1: Expansion in emerging markets represents a significant growth opportunity for Drägerwerk. Increasing healthcare spending and industrialization in regions like Asia-Pacific and Latin America create demand for the company's medical and safety solutions. By tailoring its product offerings and distribution strategies to local needs, Drägerwerk can capture a larger share of these rapidly growing markets. This expansion could contribute to a 10-15% increase in revenue over the next five years.
  • Growth opportunity 2: The increasing adoption of digital health technologies presents an opportunity for Drägerwerk to integrate its medical devices with software platforms and data analytics. By offering connected solutions that improve patient monitoring, enhance clinical decision-making, and streamline healthcare workflows, Drägerwerk can differentiate itself from competitors and capture a larger share of the digital health market. The digital health market is projected to reach $379 billion by 2024.
  • Growth opportunity 3: The growing emphasis on workplace safety and environmental protection drives demand for Drägerwerk's safety equipment and gas detection solutions. Stricter regulations and increased awareness of workplace hazards create opportunities for the company to expand its sales to industries such as oil and gas, mining, and construction. Focusing on innovative gas detection technologies and comprehensive safety training programs can strengthen Drägerwerk's position in this market.
  • Growth opportunity 4: Strategic acquisitions and partnerships can accelerate Drägerwerk's growth by expanding its product portfolio, entering new markets, and gaining access to innovative technologies. By acquiring companies with complementary products or technologies, Drägerwerk can strengthen its competitive position and offer a more comprehensive suite of solutions to its customers. Targeted acquisitions in areas such as remote patient monitoring and industrial safety can drive significant growth.
  • Growth opportunity 5: The increasing demand for home healthcare solutions presents an opportunity for Drägerwerk to develop and market medical devices and monitoring systems for use in the home. As the population ages and healthcare costs rise, there is a growing need for affordable and convenient home healthcare solutions. By offering user-friendly medical devices and remote monitoring services, Drägerwerk can tap into this growing market and improve the quality of life for patients.

Chancen

  • Expansion in emerging markets.
  • Increasing adoption of digital health technologies.
  • Growing emphasis on workplace safety and environmental protection.
  • Strategic acquisitions and partnerships.

Risiken

  • Economic downturns affecting healthcare spending.
  • Changes in government regulations.
  • Technological disruptions from new entrants.
  • Increased competition from low-cost manufacturers.

Wettbewerbsvorteile

  • Strong brand reputation and established market position.
  • Diversified product portfolio across medical and safety technology.
  • Global presence and distribution network.
  • Focus on innovation and technological leadership.

Ueber DWRKF

Drägerwerk AG & Co. KGaA, established in Lübeck, Germany in 1889, has evolved into a prominent player in the medical and safety technology sectors. Initially focused on respiratory and diving equipment, the company expanded its portfolio to include a comprehensive range of products and services for acute point of care, such as emergency care, perioperative care, critical care, and perinatal care. This includes anesthesia devices, ventilators, thermoregulation equipment, patient monitoring systems, and related consumables and accessories. Drägerwerk also caters to the safety needs of various industries and public sectors. Their offerings encompass personal protective equipment, gas detection technology, and integrated hazard management solutions for industries like mining, as well as public services like fire departments and disaster protection agencies. These products include stationary and mobile gas detection systems, alcohol and drug testing devices, and fire training facilities. With a global footprint spanning Europe, the Americas, Africa, Asia, and Australia, Drägerwerk AG & Co. KGaA serves a diverse clientele across healthcare, industrial, and public sectors. The company's commitment to innovation and quality has solidified its position as a trusted provider of critical medical and safety solutions worldwide.

Was das Unternehmen tut

  • Develops and markets system solutions for acute point of care, including emergency, perioperative, critical, and perinatal care.
  • Provides anesthesia devices and ventilators.
  • Offers thermoregulation equipment, consumables, and accessories.
  • Supplies gas management systems and patient monitoring solutions.
  • Develops and markets personal protective equipment for industrial and public sectors.
  • Offers stationary and mobile gas detection systems.
  • Provides alcohol and drug testing devices.
  • Offers training and services, including fire training facilities.

Geschaeftsmodell

  • Develops and manufactures medical and safety technology products.
  • Sells products and services directly to hospitals, industrial clients, and public sector organizations.
  • Generates revenue from product sales, service contracts, and training programs.
  • Focuses on innovation and quality to maintain a competitive advantage.

Branchenkontext

Drägerwerk AG & Co. KGaA operates within the medical devices and safety equipment industries, both experiencing steady growth driven by technological advancements, aging populations, and increasing safety regulations. The medical device market is projected to reach $600 billion by 2025, while the safety equipment market is expected to reach $60 billion. Drägerwerk competes with major players like ARHCF (Arjo), BIESF (B. Braun), and CMPUY (Coloplast), focusing on innovation and specialized solutions to maintain its competitive edge. The company's diversified portfolio allows it to capitalize on growth opportunities in both sectors.

Wichtige Kunden

  • Hospitals and healthcare providers
  • Industrial companies in sectors such as mining, oil and gas, and construction
  • Public sector organizations, including fire departments, police, and disaster protection agencies
KI-Zuversicht: 71% Aktualisiert: 15. März 2026

Finanzdaten

Chart & Info

Drägerwerk AG & Co. KGaA (DWRKF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer DWRKF verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DWRKF.

Kursziele

Wall-Street-Kurszielanalyse fuer DWRKF.

MoonshotScore

49/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von DWRKF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Stefan A. Drager

Unknown

Information on Stefan A. Drager's specific background, career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for managing the overall strategic direction and operations of Drägerwerk AG & Co. KGaA, a company with over 15,000 employees.

Erfolgsbilanz: Due to the limited information available, it is not possible to provide specific details on Stefan A. Drager's key achievements, strategic decisions, or company milestones under his leadership. His role involves overseeing the company's activities in medical and safety technology across multiple global markets.

DWRKF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Drägerwerk AG & Co. KGaA may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing standards, resulting in increased risks for investors.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC Other stock, DWRKF likely experiences lower trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more challenging for investors to buy or sell shares quickly and at desired prices. The limited liquidity may also increase price volatility, making it essential for investors to exercise caution and use limit orders to manage their risk.
OTC-Risikofaktoren:
  • Limited financial disclosure and transparency.
  • Lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Increased price volatility.
  • Potential for fraud or manipulation.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and disclosures.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review any available analyst reports or independent research.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal issues.
Legitimitaetssignale:
  • The company has been in operation since 1889.
  • Drägerwerk AG & Co. KGaA has a global presence.
  • The company operates in the regulated medical and safety technology sectors.
  • The company has a diverse product portfolio.
  • The company has a large number of employees (15,170).

DWRKF Healthcare Aktien-FAQ

What are the key factors to evaluate for DWRKF?

Drägerwerk AG & Co. KGaA (DWRKF) currently holds an AI score of 49/100, indicating low score. Key strength: Diversified product portfolio across medical and safety technology.. Primary risk to monitor: Potential: Economic downturns affecting healthcare spending.. This is not financial advice.

How frequently does DWRKF data refresh on this page?

DWRKF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven DWRKF's recent stock price performance?

Recent price movement in Drägerwerk AG & Co. KGaA (DWRKF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio across medical and safety technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider DWRKF overvalued or undervalued right now?

Determining whether Drägerwerk AG & Co. KGaA (DWRKF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying DWRKF?

Before investing in Drägerwerk AG & Co. KGaA (DWRKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding DWRKF to a portfolio?

Potential reasons to consider Drägerwerk AG & Co. KGaA (DWRKF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified product portfolio across medical and safety technology.. Additionally: Global presence and distribution network.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of DWRKF?

Yes, most major brokerages offer fractional shares of Drägerwerk AG & Co. KGaA (DWRKF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track DWRKF's earnings and financial reports?

Drägerwerk AG & Co. KGaA (DWRKF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DWRKF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data as of 2026-03-15.
  • OTC market data may have limited availability and reliability.
  • AI analysis pending for DWRKF.
Datenquellen

Popular Stocks